The control of ubiquinone biosynthesis by peroxisome proliferators was inve
stigated using peroxisome proliferator activated receptor alpha (PPAR alpha
)-null mice. Administration of 2-(diethylhexyl)phthalate to control mice re
sulted in elevated ubiquinone levels in the liver, while dolichol, dolichyl
-P and cholesterol concentrations remained unchanged. In PPAR alpha-null mi
ce, the level of these Lipids were similar to control levels and administra
tion of the peroxisome proliferator did not increase the levels of ubiquino
ne. The increase in ubiquinone levels was the result of increased synthesis
. Induction was most pronounced in Liver, kidney and heart, which have rela
tively high, levels of PPAR alpha. When the tissue concentration of hydroge
n peroxide was elevated by inhibition of catalase activity with aminotriazo
le, the amount of ubiquinone was not increased, suggesting that the inducti
on of ubiquinone synthesis occured through a direct mechanism. The activiti
es of branch-point enzymes FPP-synthase, squalene synthase, cis-prenyltrans
ferase, trans-prenyltransferase and NPHB-transferase were substantially inc
reased in control but not in PPAR alpha-null mice after treatment with pero
xisome proliferators. These data suggest that the induction of ubiquinone b
iosynthesis after administration of peroxisome proliferators is dependent o
n the PPAR alpha through regulation of some of the mevalonate pathway enzym
es. (C) 2000 Academic Press.